{ "ok": true, "cik": "1140859", "ticker": "COR", "name": "CENCORA, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-25", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926110624/0001104659-26-110624-index.htm" }, { "form": "8-K", "filed": "2026-08-14", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926097096/0001104659-26-097096-index.htm" }, { "form": "8-K", "filed": "2026-08-12", "items": [ "7.01 Regulation FD Disclosure" ], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926094676/0001104659-26-094676-index.htm" }, { "form": "10-Q", "filed": "2026-08-05", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/0001140859-26-000034-index.htm" }, { "form": "8-K", "filed": "2026-08-05", "items": [ "1.01 Entry into a Material Definitive Agreement", "2.03 Creation of a Direct Financial Obligation", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926090691/0001104659-26-090691-index.htm" }, { "form": "8-K", "filed": "2026-08-05", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000032/0001140859-26-000032-index.htm" } ], "events12m": 20, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 6, "latest": { "filed": "2026-09-25", "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926110624/0001104659-26-110624-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001140859.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1140859" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up CENCORA, INC. ($COR). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-25. 20 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-09-30", "revenue": 321332819000, "revenueGrowth1y": 0.09312270535076261, "revenueGrowthPerYear": 0.10698309409816065, "yearsOfData": 5, "operatingMargin": 0.008180306662046867, "operatingMarginPrior": 0.0073998481670543, "netMargin": 0.004879097021210274, "operatingCashFlow": 3875120000, "capitalSpending": 667981000, "freeCashFlow": 3207139000, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 4356138000, "longTermDebt": 7660773000, "longTermDebtChange": 0.7458159339081638, "revenueHistory": [ { "fiscalYearEnd": "2021-09-30", "revenue": 213988843000 }, { "fiscalYearEnd": "2022-09-30", "revenue": 238587006000 }, { "fiscalYearEnd": "2023-09-30", "revenue": 262173411000 }, { "fiscalYearEnd": "2024-09-30", "revenue": 293958599000 }, { "fiscalYearEnd": "2025-09-30", "revenue": 321332819000 } ], "totalEquity": 1508019000, "totalAssets": 76590112000, "equityRatio": 0.01968947375347878, "returnOnEquity": 1.0396513571778605, "dividendsPaid": 437081000, "payoutRatio": 0.2787837077612523, "dividendPerShare": 2.2, "dividendYearsRising": 17, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 8.02, "sharesOutstanding": 195214000, "bookValuePerShare": 7.724953128361696, "revenuePerShare": 1646.0541713196799, "range80": { "low": 320170679268.3596, "high": 364671412882.8444, "baseline": 353058427626.7099, "n": 1471, "band": "b10", "bandLabel": "$10B+", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.011946421336005944, "classVolatility": 0.06659579566308972, "volatility": 0.04784201596263152 }, "ifPaceHeld": { "low": 320170679268.3596, "high": 364671412882.8444 } }, "edgarette": "🔖 Exposure: revenue $321.3B (FY2025), total debt $7.7B. Experience: revenue up 9.3% on the year, up 10.7% a year over 4 years; operating margin 0.8%, up from 0.7%. Soundness: equity 2.0% of assets, return on equity 104.0%, payout 27.9% of profit, dividend per share up 17 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $320.2B and $364.7B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $302.4B to $384.2B. A statistical range, not company guidance. Against peers (30 filers, $50M+ revenue, its industry group): operating margin 0.8% against a 1.4% median; growth 9.3% against 0.9%.", "peers": { "sic": 5122, "sicDescription": "Wholesale-Drugs, Proprietaries & Druggists' Sundries", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "51", "growth": [ 0.0089, 31 ], "opMargin": [ 0.014, 30 ], "equityRatio": [ 0.2989, 28 ], "returnOnEquity": [ -0.0465, 21 ], "payoutRatio": [ 0.2988, 10 ] }, "summary": "Cencora (COR) grew revenue 9.3% in FY2025 to $321.3 billion, operating margin 0.8% against a 1.4% median for wholesale-drugs, proprietaries & druggists' sundries, equity 2.0% of assets, and dividend per share up 17 years running. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
CENCORA, INC. against its own record and its peers
Operating marginPeer median 1.4%0.8%Revenue, on the yearPeer median 0.9%9.3%Equity of assetsPeer median 29.9%2.0%Return on equityPeer median -4.7%104.0%Payout of profitPeer median 29.9%27.9%Gold tick: the median of 10–28 peers with $50M+ revenue in wholesale-drugs, proprietaries & druggists' sundries
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profit27.9% paid out72.1% keptHanded back per share$2.2up 17 years runningGrowth its own profit can fund75.0%retained x return on equityRevenue growth it managed9.3%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 15, "hits": 12, "rate": 0.8, "method": "v4", "byYear": { "2011": [ 1, 1 ], "2012": [ 1, 1 ], "2013": [ 0, 1 ], "2014": [ 0, 1 ], "2015": [ 1, 1 ], "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:35:48.236Z", "hash": "38d920ac3643638c", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Cencora (COR) grew revenue 9.3% in FY2025 to $321.3 billion, operating margin 0.8% against a 1.4% median for wholesale-drugs, proprietaries & druggists' sundries, equity 2.0% of assets, and dividend per share up 17 years running. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-09-30", "revenue": 321332819000, "totalDebt": 7660773000, "cash": 4356138000 }, "experience": { "revenueGrowth1y": 0.09312270535076261, "revenueGrowthPerYear": 0.10698309409816065, "operatingMargin": 0.008180306662046867, "operatingMarginPrior": 0.0073998481670543, "netMargin": 0.004879097021210274, "freeCashFlow": 3207139000 }, "soundness": { "equityRatio": 0.01968947375347878, "returnOnEquity": 1.0396513571778605, "payoutRatio": 0.2787837077612523, "dividendPerShare": 2.2, "dividendYearsRising": 17, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 5122, "sicDescription": "Wholesale-Drugs, Proprietaries & Druggists' Sundries", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "51", "growth": [ 0.0089, 31 ], "opMargin": [ 0.014, 30 ], "equityRatio": [ 0.2989, 28 ], "returnOnEquity": [ -0.0465, 21 ], "payoutRatio": [ 0.2988, 10 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 6, "latest": { "filed": "2026-09-25", "url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465926110624/0001104659-26-110624-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 320170679268.3596, "high": 364671412882.8444, "baseline": 353058427626.7099, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 1471, "sizeBand": "$10B+", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.011946421336005944, "classVolatility": 0.06659579566308972, "pricedVolatility": 0.04784201596263152, "k": 3 }, "stress": { "low": 302379964007.40405, "high": 384193585508.0748, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 15, "hits": 12, "rate": 0.8, "method": "v4", "byYear": { "2011": [ 1, 1 ], "2012": [ 1, 1 ], "2013": [ 0, 1 ], "2014": [ 0, 1 ], "2015": [ 1, 1 ], "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:35:48.236Z", "hash": "38d920ac3643638c", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001140859.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1140859" }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0121, "growth3y": 0.1043, "volatility": 0.0119, "paysDividend": true, "raisedDividend": true, "equityRatio": 0.0244, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 1.2% of revenue into operating cash; revenue growing 10.4% a year over three years; pays and raised its dividend.", "outside": "Among $10B+ companies: 7th percentile for cash, 78th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$10B+", "cashPctInClass": 7, "growthPctInClass": 78, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-09-30", "operating": 3875120000, "investing": -4977293000, "financing": 2249114000, "capitalSpending": 667981000, "free": 3207139000, "trend": [ { "fiscalYearEnd": "2021-09-30", "operating": 2666586000, "free": 2228369000 }, { "fiscalYearEnd": "2022-09-30", "operating": 2703088000, "free": 2206770000 }, { "fiscalYearEnd": "2023-09-30", "operating": 3911334000, "free": 3452975000 }, { "fiscalYearEnd": "2024-09-30", "operating": 3484685000, "free": 2997512000 }, { "fiscalYearEnd": "2025-09-30", "operating": 3875120000, "free": 3207139000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-09-30", "cash": 4356138000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 76590112000, "ladder": null, "currentRatio": 0.9, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0121, "growth3y": 0.1043, "volatility": 0.0119, "paysDividend": true, "raisedDividend": true, "equityRatio": 0.0244, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 1.2% of revenue into operating cash; revenue growing 10.4% a year over three years; pays and raised its dividend.", "outside": "Among $10B+ companies: 7th percentile for cash, 78th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$10B+", "cashPctInClass": 7, "growthPctInClass": 78, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-09-30", "operating": 3875120000, "investing": -4977293000, "financing": 2249114000, "capitalSpending": 667981000, "free": 3207139000, "trend": [ { "fiscalYearEnd": "2021-09-30", "operating": 2666586000, "free": 2228369000 }, { "fiscalYearEnd": "2022-09-30", "operating": 2703088000, "free": 2206770000 }, { "fiscalYearEnd": "2023-09-30", "operating": 3911334000, "free": 3452975000 }, { "fiscalYearEnd": "2024-09-30", "operating": 3484685000, "free": 2997512000 }, { "fiscalYearEnd": "2025-09-30", "operating": 3875120000, "free": 3207139000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-09-30", "cash": 4356138000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 76590112000, "ladder": null, "currentRatio": 0.9, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }